The shifting paradigm in the management of giant congenital melanocytic nevi: review and clinical applications.
The shifting paradigm in the management of giant congenital melanocytic nevi: review and clinical applications.
复制标题
巨大先天性黑素细胞痣治疗模式的转变:回顾和临床应用。
DOI:
10.1097/prs.0000000000000546
复制
发表时间:
2014
影响因子:
3.6
通讯作者:
A. Marghoob
中科院分区:
文献类型:
--
作者:
B. Bauer;S. Dickie;A. Marghoob
659e could compare the results of each reviewer. In order to attempt to remedy the disagreements that we appreciated, we created the mild (0 to I), moderate (IIA), severe (IIB to III) classification. This result improved rater agreement, but by less than we would have expected. In a second attempt to remedy the lack of a quality accepted standard, we utilized the Fleiss kappa statistic3 to assess for interrater variability among all study participants. Again, we appreciated a lack of interrater agreement among reviewers (κ = 0.238, 0.438). While Kaban et al.’s criticism that this study tests the application of the reviewers’ understanding of the Pruzansky modification of the Kaban classification is well received, this is indeed the way the Pruzansky modification is currently being applied in clinical practice. A classification schema derives its efficacy and, thus, clinical import by being readily understood and ultimately reproducible. Our results indicate that neither may be true of the Pruzansky modification of the Kaban classification system when paired with modern imaging modalities. There is no debate that the Pruzansky modification remains the classification system of choice; each of our study participants—trained craniofacial surgeons—acknowledged using it in their practice. Each participant was shown the correct original definition of the Pruzansky modification prior to undertaking the study survey, with a type IIA mandible being defined as “abnormal in shape.” We apologize for the error in the legend of Figure 1; however, the mislabeling of the images as Kaban et al. define it is an example of a possible disagreement among physicians that we appreciated in our study. I believe, though, that we are in agreement that the treatment of choice would not differ in either of these cases. Again, we appreciate their thoughtful criticisms of our study and agree, “A classification system should aid in diagnosis of a condition, improve communication among clinicians, help predict progression of disease/ deformity, and guide research.” We hope that with the resources available to us, we were able to conduct a study that demonstrated the immense difficulty of classifying patients with a diagnosis of hemifacial microsomia in a reliable and reproducible manner. The use of threedimensional computed tomography has allowed physicians to clearly visualize the complexity of each case of hemifacial microsomia. We believe that the information available in each three-dimensional computed tomography scan may hold the key to classifying this extremely amorphous disorder in a more objective manner. DOI: 10.1097/PRS.0000000000000705